| Papillary Adenocarcinoma altered in cohorts of …ALTERED_INderived196 of 196show fewer |
|---|
| ← altered in cohorts of | HELZ 187 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MED13 187 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MRC2 187 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF213 187 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACE 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPTF 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC57 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLTC 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNH6 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TEX2 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBE2O 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP32 186 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCA8 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCAF7 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EFCAB3 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNA13 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNJ16 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIF19 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC37A3 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NOL11 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NPTX1 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POLG2 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPM1D 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKAR1A 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | QRICH2 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF157 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMURF2 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOX9 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBCD 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBX4 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMC6 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNRC6C 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UNC13D 185 / 291 cases (64 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCA10 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCA9 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AKAP1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APOH 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARSG 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AXIN2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BCAS3 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BRIP1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C17orf80 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CACNG5 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CARD14 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBX4 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CD300C 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CD79B 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP131 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COG1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSH1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSH2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DDX42 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DDX5 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAI2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF4A3 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERN1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EVPL 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM20A 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FASN 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBF1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FDXR 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXJ1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GH1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GH2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR142 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HLF 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSF5 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ICAM2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGBP1P2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INTS2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNJ2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KPNA2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP2K6 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MARCHF10 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMD 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NARF 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAT9 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PECAM1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PITPNC1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RGS9 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RHBDF2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF43 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SIRT7 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC16A6 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC39A11 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMARCD2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPHK1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SRSF1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ST6GALNAC2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STRADA 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TACO1 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBX2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TEX19 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TLK2 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMC8 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USH1G 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP36 184 / 291 cases (63 %) · ssm · TCGA-KIRP | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BRAF 293 / 496 cases (59 %) · ssm · thpa_tcga_gdc · largest of 4 cohorts | — | — | Thyroid Gland Papillary Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OR11H12 104 / 394 cases (26 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM243B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNE1B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM11B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM34B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR11H1 98 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEH 96 / 394 cases (24 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTNAP3C 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A7 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A5 88 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L5 87 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A4P 85 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD5 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L4 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEM 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A3P 79 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF658 77 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A3 76 / 394 cases (19 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEG 70 / 394 cases (18 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TPTE 68 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A1 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM86B2 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LINC02203 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4F4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4M2 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4N4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RABL2B 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L3 65 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A6 62 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACR 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB130A 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB2 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRP7A 59 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHANK3 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC1 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHEK2 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTNAP3B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB105B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB106B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB107B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND6B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A10P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A17P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A19P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A8P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A9P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSCB 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADM2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALG12 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARSA 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC117 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHKB 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHKB-CPT1B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CRELD2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB103B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB104A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB104B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB105A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB106A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB107A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB4B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A16P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A18P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A22P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A23P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A7P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL17REL 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHDC7B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LMF2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK11 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK12 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK8IP2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MIOX 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MLC1 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCAPH2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ODF3B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIM3 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLXNB2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP6R2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRR23D1 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SBF1 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCO2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SELENOO 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPAG11A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPAG11B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYCE3 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRABD 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TUBGCP6 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TYMP 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBED4 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 35 / 282 cases (12 %) · ssm · kirp_tcga · largest of 3 cohorts | — | — | Papillary Renal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 24 / 282 cases (8.5 %) · ssm · kirp_tcga · largest of 3 cohorts | — | — | Papillary Renal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NRAS 39 / 496 cases (7.9 %) · ssm · thpa_tcga_gdc · largest of 4 cohorts | — | — | Thyroid Gland Papillary Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TERT 37 / 496 cases (7.5 %) · ssm · thca_tcga_pub | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MET 21 / 282 cases (7.4 %) · ssm · kirp_tcga · largest of 3 cohorts | — | — | Papillary Renal Cell Carcinoma | 3 | Observed | cbioportal | graph → |